Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research

Contract Research

Nuvilex forms Diabetes consortium to develop treatment for Insulin-Dependent Diabetes Nuvilex, a clinical-stage biotechnology company providing cell therapy solutions for the treatment of diseases, has formed a 'Diabetes Consortium' that will be tasked with the development of Nuvilex's treatment for insulin-dependent diabetes.
Contract Research & Services > Contract Research > News
Transposagen enters into research collaboration with Janssen for Allogeneic CAR T-Cell therapies Transposagen Biopharmaceuticals, a private biotechnology company headquartered in Lexington, KY, they have entered into a research collaboration and worldwide license agreement with Janssen Biotech (Janssen) to develop allogeneic Chimeric Antigen Receptor T-cells (CAR-T).
Contract Research & Services > Contract Research > News Sevion, Avidity NanoMedicines enter research agreement for chimerasome By PBR Staff Writer
US-based Sevion Therapeutics (SVON) has entered into a research agreement with Avidity NanoMedicines related to the use of SVON's chimerasome technology for delivery of nucleic acids.
Contract Research & Services > Contract Research > News
See more Contract Research news

Latest Contract Research News and Insight

View all Contract Research news or find news targeted to your interests
Early Phase Clinical Research in Italy
| By Cromsource
In recent years, the legislation in Italy which governs clinical research activity has undergone important changes. These revisions also affected the conduct of early phase clinical research, including Phase 1. Specifically, legislation introduced in 1998, 2001, 2003, 2007 and 2012 introduced changes which are relevant to the conduct of Phase I studies in Italy.
Contract Research & Services > Contract Research > White Papers
OnCore, Blumberg enter exclusive HBV research collaboration
By PBR Staff Writer
US-based OnCore Biopharma has entered into a hepatitis B virus (HBV) and liver cancer research collaboration with the Baruch S. Blumberg Institute (Blumberg), the research center of the Hepatitis B Foundation.
Contract Research & Services > Contract Research > News
CDISC and TransCelerate announce availability of new standards for diabetes and cardiovascular disease
The Clinical Data Interchange Standards Consortium and TransCelerate BioPharma are pleased to announce the availability of therapeutic area (TA) standards for diabetes and cardiovascular (CV) disease areas through the Coalition for Accelerating Standards and Therapies (CFAST), a joint initiative of CDISC and the Critical Path Institute (C-Path).
Contract Research & Services > Contract Research > News
ULTImate YChemH
Find out more about your small molecule effects thanks to our drug discovery service. ULTImate Yeast Chemical Hybrid (YChemH) is a compound profiling technique adapted from our ULTImate Y2H™ technology to identify the protein partners of a given bioactive small molecule.
Contract Research & Services > Contract Research > Products
Alliance for Children’s Therapeutics to expand pediatric research to MS, IBD and asthma
The Alliance for Children’s Therapeutics announced it will expand its pediatric research into multiple sclerosis (MS), inflammatory bowel disease (IBD), and asthma.
Contract Research & Services > Contract Research > News
Boehringer, WellPoint and HealthCore start new multi-year research collaboration
By PBR Staff Writer
Boehringer Ingelheim Pharmaceuticals (BIPI), WellPoint and HealthCore are starting a research project to identify gaps in non-valvular atrial fibrillation research, development and treatment.
Contract Research & Services > Contract Research > News
Bristol Myers reports positive Phase III trial results of melanoma drug Opdivo
By PBR Staff Writer
Bristol Myers Squibb (BMS) has reported positive results from a Phase III trial (CheckMate -066) comparing an investigational PD-1 immune checkpoint inhibitor, Opdivo, to the chemotherapy dacarbazine (DTIC) in patients with treatment naïve BRAF wild-type advanced melanoma.
Contract Research & Services > Contract Research > News
Woodley Equipment Company Announces the Appointment of Monika Hrdinkova
Woodley Equipment Company is pleased to announce the appointment of Monika Hrdinkova as office administrator working for our clinical trials division at our Hopkinton office near Boston, Massachusetts, US. Monika has extensive business management, customer service and logistics experience and Monika’s appointment will further strengthen the clinical trials customer service team.
Contract Research & Services > Contract Research > Press Releases
GSK seeks proposals for non-communicable diseases research in Africa
By PBR Staff Writer
British drugmaker GlaxoSmithKline (GSK) is seeking proposals for its Africa non-communicable diseases (NCDs) Open Lab, to support the scientific research into NCDs in the continent.
Contract Research & Services > Contract Research > News
Dynasil's RMD subsidiary gets $3.5m in technology development grants from NIH
Dynasil Corporation of America announced that its contract research subsidiary, RMD, has received three grants totaling $3.5m under the National Institute of Health's Small Business Innovation Research (SBIR) Program.
Contract Research & Services > Contract Research > News
View all Contract Research news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250